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Abstract No data exist on the trigger for platelet
transfusions in adult thrombocytopenic patients with
acute leukemia undergoing lumbar puncture (LP). We
reviewed the records of 66 patients with acute leukemia
(median age 38 years, range 18–68) who have been
treated in our institution for 6 years. A total of 195 LPs
were performed. No serious hemorrhagic complications
occurred, but there was a significant trend towards a
higher percentage of traumatic procedures, defined as the
occurrence of >500 erythrocytes per high-power field, in
patients with lowest platelet counts (p<0.005). Although
not associated with serious clinical bleeding events in this
study, the increased occurrence of traumatic procedures
may indicate an increased risk for more serious hemor-
rhagic complications, implying a trigger not lower than
20109/L for prophylactic transfusions of platelets in
adult patients with acute leukemia undergoing LP.
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Introduction
Platelet transfusions are increasingly demanded in pa-
tients with hematologic malignancies. However, the
recruitment of platelet donors is difficult, and repeated
use of platelet transfusions is associated with increasing
risk of transfusion reactions, transfusion-transmitted dis-
eases, alloimmunization, and considerable costs. Thus,
current guidelines recommend restrictive prophylactic
strategies [10].
Multiple randomized trials support a threshold of
10109/L, above which prophylactic transfusion is con-
sidered unnecessary in the absence of hemorrhage in
stable, non-febrile patients with acute leukemia [5, 8].
Nevertheless, there is still uncertainty about the lower
level of platelet count that is safe in thrombocytopenic
patients with leukemia undergoing invasive procedures,
e.g., diagnostic or therapeutic lumbar punctures (LP) [10].
Whereas a recent large retrospective review and a follow-
up study showed that platelet counts as low as 10109/L
may be sufficient for safe LP in children with lympho-
blastic leukemia [6, 7], firm data in adult patients with
acute leukemia are lacking. Based on the occurrence of
severe bleeding complications following LP in patients
with platelet counts below 20109/L, a platelet count of
20109/L was recommended as threshold for platelet
transfusions prior to LP in adults [1, 3]. However, no
systematic study has tested this recommendation so far.
In our institution, restrictive strategies for prophylactic
platelet transfusions are used [4] and the recommendation
of transfusing platelets only when counts are lower than
20109/L prior to LP has long been adopted. Herein we
describe our experience in using this strategy in adult
patients with acute leukemia undergoing LP.
Patients and methods
Study design and patient population
We retrospectively analyzed the medical charts of patients with
acute leukemia who were treated from January 1995 to February
2001 at the University Hospital Zurich, Switzerland, and underwent
one or more therapeutic or prophylactic lumbar puncture(s) (LP).
To be included in the analysis, the patient had to be at least 18 years
old, and coverage of a follow-up period of at least 14 days after the
LP was required. The basic characteristics of the patients are
summarized in Table 1. We recorded platelet counts on the morning
of LP, as well as the 1-h platelet count after transfusion, in case
transfusion was required. Results were available for high-powered
field (HPF) microscopic examinations of cerebrospinal fluid (CSF).
A traumatic LP was defined if >500 red blood cells were present
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per HPF. Clinical events that were potentially attributed to LP
procedures and all neurologic, infectious, or hemorrhagic events
that occurred within 14 days after LP were noted. Headache,
nausea, irritability or somnolence, and low back pain were
excluded.
Statistics
Results are presented as median (range). Nonparametric statistical
tests were used throughout. Continuous variables between groups
were compared using a two-tailed Mann-Whitney U test or a
Kruskal-Wallis one-way analysis of variance with Dunn’s Multiple
Comparisons Tests. Discontinuous variables were analyzed by the
Chi-squared test for trend. The 95% confidence intervals (CIs) for
the probability of serious hemorrhagic complications at each level
of platelet counts were defined using the exact confidence limits
based on a binominal distribution; for the upper bound of the
confidence interval, the formula p=1–0.025(1/n) was used [2].
Statistical calculations were performed using InStat version 3.05
(GraphPad, San Diego, CA, USA). p<0.05 was considered
significant.
Results and discussion
We retrospectively identified 66 patients who were
treated with intensive chemotherapy regimens and/or
bone marrow transplantation for hematologic malignan-
cies and met our inclusion criteria; Table 1 summarizes
their basic characteristics. These patients underwent a
total of 195 LPs (24 diagnostic, 171 therapeutic, Table 2).
Results from CSF examinations were available from all
but 16 LPs, which were nevertheless included in the
analysis since the patients were assessable for potential
complications. On the morning of the day of the
scheduled LP, 37 patients had platelet counts below
20109/L and received platelets according to the institu-
tion’s transfusion criteria. Afterwards, the effect of
transfusion was verified with a 1-h post-transfusion count,
and the LP was performed only when platelet counts
increased to values higher than 20109/L. The platelet
counts at the time of LP are shown in Table 2. A
traumatic puncture, defined as the occurrence of >500
erythrocytes/HPF, was noted after 14 procedures (6,7%).
There was a significant trend towards higher percentage
of traumatic punctures in patients with lower platelet
counts (Chi-square test for trend: 9.46, p<0.005). Table 3
shows the characteristics of the patients with platelet
counts <25109/L at the time of LP. In none of the 195
procedures, however, occurred more serious bleeding
events or other adverse sequelae.
A total of five adverse events (meningoencephalitis,
leukencephalopathy, meningism, tonic-clonic seizure, and
transient ischemic attack) that were considered potentially
related to LP procedures were found. All events occurred
after a therapeutic, non-traumatic LP and did not appear
to be associated with patients with lower platelet counts
(range of platelet counts at LP: 23–247109/L).There was
no evidence for underlying bleeding in any of these
patients, both by radiological means and by repeated LP,
which were all non-hemorrhagic. Thus, given the fact that
there was no clinical or laboratory evidence for hemor-
rhage, these adverse events were not considered related to
thrombocytopenia-associated bleeding and were not in-
cluded in the estimation of probability of serious bleeding
complications following LP. A more likely explanation
for the adverse events was local irritation by instilled
chemotherapy in cases with meningeal symptoms occur-
Table 2 Clinical conditions at time of lumbar punctures and results from cerebrospinal fluid analysis
Platelet count at LP
All 20–30109/L 31–50109/L 51–100109/L >101109/L
Number of LPs performed (n) 195 35 40 43 77
Diagnostic/therapeutic (n) 24/171 5/30 7/33 4/39 8/69
Patients requiring transfusion (n)* 37 16 10 11 0
Platelet counts at LP (x109/L)** 32 (20–893) 24.5 (20–30) 37.5 (31–42) 60 (51–85) 227 (102–893)
Hemostatic parameter (INR) 1.1 (0.8–1.7) 1.1 (0.9–1.4) 1.2 (0.9–1.7) 1.1 (0.8–1.3) 1 (0–8-1.4)
Temperature (C) 37.8 (36.2–39.9) 37.9 (36.4–39.5) 38.3 (36.9–39.9) 37.8 (37–39.4) 37 (36.2–39.6)
Cerebrospinal fluid analysis, number of LPs with
Blast cells 15 2 4 4 5
Erythrocytes >500 HPF 14 6 4 3 1
Quantitative variables are expressed as median (range); qualitative variables are expressed as n. HPF high-power field.
* patients received platelet transfusions when platelet counts were below 20109/L on the day of LP; platelet counts were re-determined
1 h after transfusion
** shown is last platelet count measurement prior to LP, i.e., morning value in patients who did not receive platelet transfusions on the day
of LP or 1h post-transfusion counts in patients who received platelet transfusions
Table 1 Basic characteristic of 66 patients with acute leukemia
undergoing lumbar puncture
Demographics
Number of patients (female/male) 66 (29/37)
Age, years (range) 38 (18–68)
Diagnosis
Acute myeloid leukemia AML total (n) 28
AML M1 2
AML M2 5
AML M4 13
AML M5 7
AML M6 1
Acute lymphoblastic leukemia (n) 38
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ring shortly after LP, as well as in the patient with
radiological evidence for leukencephalopathy. The patho-
genesis of the transient-ischemic attack or the menin-
goencephalitic symptoms that occurred over 3 weeks after
the LP remained unclear, but a causal relationship to the
LP procedure was questionable.
Therefore, we did not observe any serious bleeding
event in our study population. However, a major limita-
tion of the present study is its limited sample size, which
precludes any firm conclusion about the precise risk for
serious bleeding events. To take this limitation into
account, we performed an additional statistical analysis to
determine the statistical probability of serious hemor-
rhagic complications based on our data. As shown in
Table 4, the 95% confidence interval is rather wide,
reflective of the relatively limited number of procedures
performed.
There is still controversy about the trigger for platelet
transfusions in adult patients with acute leukemia [10].
Although a recent large study showed that platelet counts
as low as 10109/L seem to be safe in children with acute
leukemia [6, 7] these results may not be transferable to
adults, in which LPs may be more difficult to perform and
therefore more prone to complications. Defining firm
criteria for the trigger of prophylactic platelet transfusions
in thrombocytopenic adults with leukemia is of consid-
erable interest for medical and economic reasons.
Our results suggest that the trigger for platelet
transfusions when performing LPs may be as low as
20109/L in adult patients with acute leukemia. Caveats
have to be included, however. First, although this is so far
the largest study investigating the trigger for platelet
transfusion in this patient population, the actual number
of procedures is still relatively small, and statistical means
are necessary to more adequately determine the proba-
bility of serious complications. And second, there was a
significant trend towards a higher percentage of proce-
dures with hemorrhagic CSF in patients with lower
platelet counts. Although such procedures may not
account as serious hemorrhagic complication per se, a
traumatic LP was shown to be associated with a higher
incidence of severe complications in non-thrombocy-
topenic control patients and patients with heparin therapy
[9], and it is conceivable to assume that this could also be
true for thrombocytopenic patients. If true, our data would
suggest that patients with the lowest platelet counts at the
time of the LP might be at a slightly higher risk for
serious hemorrhagic complications. Together with the
previous observation of severe bleeding complications
following LP in adult patients with platelet counts below
20109/L [1, 3], the present study supports a trigger not
lower than 20109/L for prophylactic platelet transfusion
in adult patients with acute leukemia in whom a
diagnostic or therapeutic LP is to be performed.
Table 3 Overview of 17 patients with platelet counts <25109/L at LP
Patients Age (y) Gender Platelet count at LP (x109/L)* Substitution** Hemorrhagic LP Side effects
1. 50 M 20 – – –
2. 42 F 20 – – –
3. 42 F 20 – + –
4. 55 F 20 + – –
5. 38 M 21 – – –
6. 28 M 21 + + –
7. 65 F 21 + – –
8. 48 F 21 + – –
9. 25 M 22 – – –
10. 44 M 22 + – –
11. 21 F 23 – – –
12. 28 M 23 – – –
13. 42 F 23 – – –
14. 18 M 23 + – Meningoencephalitis
15. 48 F 24 - – –
16. 67 M 24 + + –
17. 18 M 24 + – –
*Shown is last platelet count measurement prior to LP, i.e., morning value in patients who did not receive platelet transfusions on the day
of LP or 1-h post-transfusion counts in patients who received platelet transfusions
**Denotes platelet transfusion on day of LP
Table 4 Platelet counts, num-
ber of lumbar punctures (LPs)
performed, and the estimated
probability of serious compli-
cations
Platelet count (109/L) No. of LPs 95% CI for complications (%)
20–30 35 0.00–10.0
30–50 40 0.00–8.81
50–100 43 0.00–8.22
>100 77 0.00–4.68
Total 195 0.00–1.87
CI confidence interval
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